Amgen seeks licensing opportunities that match our strategy and expand our capabilities in oncology and hematology, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, and discovery research and technology.
Oncology & Hematology
- Novel Therapeutics
- Signal Transduction
- Cell Cycle
- Apoptosis
- Hematopoiesis
- Anemia
- Neutropenia
- Stem Cell Mobilization
- Supportive Care
Nephrology
- Renal Failure
- Hyperparathyroidism
Inflammation
- Rheumatoid Arthritis
- Psoriasis
- Systemic Lupus Erythematosus
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Asthma/COPD
- Osteoarthritis
Cardiovascular
- Acute Coronary Syndromes
- Dyslipidemia
- Heart Failure
Metabolic Disorders
- Diabetes
- Metabolic Syndrome
- Osteoporosis
Neuroscience
- Pain
- Alzheimer's Disease
- Parkinson's Disease
- Sleep Disorder
- Cognition
- Schizophrenia
Discovery Research and Technology
- Early-Stage Drug Discovery Collaborations
- Innovative Chemical Entity Collections
- Diagnostics/Biomarkers
- Novel Antibody Platforms
- Assay Biologicals and Devices
- Target-Focused Structural Biology and Computational Tools
